Search results
Information on investments, active portfolio, exits, fund performance, dry powder, team and co-investors for Coastview Capital. Use the PitchBook Platform to explore the full profile.
OVERVIEW: Gordon Binder and his wife Adele conduct their philanthropy through the Binder Foundation, which, according to available tax filings, gave away around $1 million in 2017. Binder serves on the board of American Enterprise Institute, which has received the foundation’s largest gifts lately.
3 mar 2002 · Almost a year after starting a local biomedical venture capital firm, retired Amgen Inc. Chairman Gordon Binder is close to raising his first fund, which is set at $100 million, sources say.
Harvard Business Review; Initiatives; News; Recruit; Map / Directions; Entrepreneurship. Events; Join our Mailing List; ... Gordon M. Binder MBA 1962. Related Links. Alumni Achievement Awards 2000: Gordon M. Binder. Title Founder & Managing Director. Company Coastview Capital Related Links. Alumni Achievement Awards 2000: Gordon M. Binder ...
Mr. Gordon Binder is the Chairman of the Board of Directors of NEUVOGEN. He was Chief Executive Officer of Amgen, Inc. the world’s largest biotech company, from 1988 through 2000.
Former Amgen CEO Gordon Binder recounts his biotech company's history in clear, articulate prose. He and writer Philip Bashe make the science accessible. They explain technical terms in lay language and spell out the benefits and effects of each biotech advance.
He is the Founder and Managing Director of Coastview Capital, a private investment firm. [1] [3] [5] He also serves as Chairman of SRU Biosystems. [6] He sits on the Boards of Directors of Acadia Pharmaceuticals , Cellular Genomics, PhRMA and the Biotechnology Industry Organization .
